Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2012
06/14/2012WO2012076193A1 Combination preparations comprising exosomes and corticosteroid
06/14/2012WO2012075684A1 Lactobacillus strains and use thereof for regulating immune response
06/14/2012WO2012075606A1 New pharmaceutic use of benzoic aicd derivatives
06/14/2012US20120149778 Compounds
06/14/2012US20120149771 Method for treating airway hyper-responsiveness with lipoxin analogs
06/14/2012US20120149769 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders
06/14/2012US20120149752 Kit for balancing neurotransmitter levels
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149735 1,4-Dihydropyridine Derivatives and Their Uses
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149730 Methods and compositions using racemic, (r)-, and (s)-fexofenadine in combination with leukotriene inhibitors
06/14/2012US20120149706 Inhibition of p38 kinase activity using substituted heterocyclic ureas
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149691 Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors
06/14/2012US20120149690 Compositions Comprising Azelastine and Methods of Use Thereof
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149680 Kinase inhibitors
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149656 WATER SOLUTION OF 20(R) - GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120149642 Fibrosis inhibitor for implanted organ
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120148695 Pharmaceutical Compositions From Carapa Guianensis
06/14/2012US20120148683 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
06/14/2012US20120148676 Artificial cell constructs for cellular manipulation
06/14/2012US20120148666 Anti-rsv immunogens and methods of immunization
06/14/2012US20120148663 Lipophilic drug carrier
06/14/2012US20120148629 Nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children
06/14/2012US20120148628 Compositions and methods for treatment of cancer
06/14/2012US20120148627 Compositions and Methods for Treatment of Neoplastic Disease
06/14/2012US20120148626 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148623 Vaccination for lawsonia intracellularis
06/14/2012US20120148622 Live Attenuated Influenza Virus Vaccines Comprising Microrna Response Elements
06/14/2012US20120148620 Compositions and methods for vaccinating cattle
06/14/2012US20120148619 Adjuvanting meningococcal factor h binding protein
06/14/2012US20120148618 Multiple variants of meningococcal protein nmb1870
06/14/2012US20120148617 Multiple variants of meningococcal protein nbm1870
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148612 Grass peptides for vaccine
06/14/2012US20120148611 Cyclophosphamide in Combination with Anti-Idiotypic Vaccines
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148593 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148585 Fusion molecules and methods for treatment of immune diseases
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148577 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
06/14/2012US20120148576 Humanized anti-cd 19 antibody formulations
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148570 Methods and compositions for treating respiratory disease-challenged animals
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148544 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148526 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012US20120148503 Non-flammable insecticide composition and uses thereof
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012CA2824619A1 Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies
06/14/2012CA2820884A1 Polycyclic lpa1 antagonist and uses thereof
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820642A1 Galectin-9-secreting cell, and production method and use of the same
06/14/2012CA2820065A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/14/2012CA2819366A1 Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
06/14/2012CA2818936A1 Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative
06/14/2012CA2818011A1 Oligosaccharide composition for treating skin diseases
06/14/2012CA2817122A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/13/2012EP2463307A1 Modified chaperonin 10
06/13/2012EP2463289A1 Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
06/13/2012EP2462928A1 Sheet-form preparation and method for producing the same
06/13/2012EP2461690A1 Lipidated oxoadenine derivatives
06/13/2012EP2001841B1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
06/13/2012EP1947110B1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli
06/13/2012EP1740192B1 Cyclic dinucleotide for stimulating the immune of inflammatory response
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012EP1613273B1 Recombinant il-9 antibodies and uses thereof
06/13/2012EP1587542B1 Use of anti-cd100 antibodies
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof
06/13/2012CN102498113A Macrocyclic inhibitors of jak
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497879A Single-time vaccines
06/13/2012CN102497872A Inhibitor of inflammatory conditions
06/13/2012CN102497868A Mixture of non-digestible oligosaccharides for stimulating the immune system
06/13/2012CN102492596A Body-building and health-care medicinal liquor
06/13/2012CN102492051A Polygonatum odoratum deep processing and comprehensive utilization process
06/13/2012CN102492038A Anti-human Tim-3 neutralized monoclonal antibody L3D and application thereof
06/13/2012CN102492034A Rice field eel serum transferrin, preparation method and use thereof
06/13/2012CN102492020A Pidotimod compound and new preparation method thereof
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 1172